| Economic implications of hip fracture: health service use, institutional care and cost in Canada ME Wiktorowicz, R Goeree, A Papaioannou, JD Adachi, ... Osteoporosis international 12, 271-278, 2001 | 541 | 2001 |
| Mortality, independence in living, and re-fracture, one year following hip fracture in Canadians A Papaioannou, M Wiktorowicz, JD Adachi, R Goeree, ... Journal SOGC 22 (8), 591-597, 2000 | 102 | 2000 |
| Emergent patterns in the regulation of pharmaceuticals: institutions and interests in the United States, Canada, Britain, and France ME Wiktorowicz Journal of Health Politics, Policy and Law 28 (4), 615-658, 2003 | 88 | 2003 |
| Improving social accountability processes in the health sector in sub-Saharan Africa: a systematic review G Danhoundo, K Nasiri, ME Wiktorowicz BMC public health 18, 1-8, 2018 | 75 | 2018 |
| Report: four decades of mental health policy in Ontario, Canada T Schrecker, JS Hoch, C Sharp Administration and Policy in Mental Health 31 (1), 2003 | 56 | 2003 |
| Pharmacovigilance in Europe and North America: divergent approaches M Wiktorowicz, J Lexchin, K Moscou Social Science & Medicine 75 (1), 165-170, 2012 | 50 | 2012 |
| Regulating biotechnology: a rational-political model of policy development M Wiktorowicz, R Deber Health policy 40 (2), 115-138, 1997 | 36 | 1997 |
| Mental health network governance: comparative analysis across Canadian regions ME Wiktorowicz, MJ Fleury, CE Adair, A Lesage, E Goldner, S Peters International Journal of Integrated Care 10, 2010 | 34 | 2010 |
| Keeping an eye on prescription drugs, keeping Canadians safe: active monitoring systems for drug safety and effectiveness in Canada and internationally. 2010 Health Council of Canada, ME Wiktorowicz | 32 | 2010 |
| Technology Acquisition in Canadian Hospitals: How is it done, and where is the information coming from? R Deber, M Wiktorowicz, P Leatt, F Champagne Healthcare Management Forum 7 (4), 18-27, 1994 | 28 | 1994 |
| Regulation of Myelin Basic Protein Gene Transcription in Normal and shiverer Mutant Mice M Wiktorowicz, A Roach Developmental neuroscience 13 (3), 143-150, 1991 | 28 | 1991 |
| A pandemic treaty, revised international health regulations, or both? R Labonté, M Wiktorowicz, C Packer, A Ruckert, K Wilson, S Halabi Globalization and Health 17, 1-4, 2021 | 24 | 2021 |
| Models of concurrent disorder service: policy, coordination, and access to care M Wiktorowicz, A Abdulle, K Di Pierdomenico, SA Boamah Frontiers in Psychiatry 10, 61, 2019 | 20 | 2019 |
| Research networks involved in post-market pharmacosurveillance in the United States, United Kingdom, France, New Zealand, Australia, Norway and European Union: Lessons for Canada ME Wiktorowicz, J Lexchin, M Paterson, B Mintzes, C Metge, D Light, ... Canadian Patient Safety Institute, 2000 | 20 | 2000 |
| Governing global antimicrobial resistance: 6 key lessons from the Paris Climate Agreement I Weldon, S Rogers Van Katwyk, GL Burci, TC De Campos, ... American Journal of Public Health 112 (4), 553-557, 2022 | 19 | 2022 |
| Keeping an eye on prescription drugs, keeping Canadians safe M Wiktorowicz, J Lexchin, K Moscou, A Silversides, L Eggertson Toronto: Health Council of Canada, 2010 | 18 | 2010 |
| Governance of natural health products regulation: an iterative process R Walji, M Wiktorowicz Health Policy 111 (1), 86-94, 2013 | 16 | 2013 |
| Shifting priorities at the health protection branch: challenges to the regulatory process ME Wiktorowicz Canadian Public Administration 43 (1), 1-22, 2000 | 15 | 2000 |
| Governance of mental healthcare: Fragmented accountability ME Wiktorowicz, K Di Pierdomenico, NJ Buckley, S Lurie, G Czukar Social Science & Medicine 256, 113007, 2020 | 14 | 2020 |
| Transnational pharmacogovernance: emergent patterns in the jazz of pharmaceutical policy convergence M Wiktorowicz, K Moscou, J Lexchin Globalization and health 14, 1-20, 2018 | 13 | 2018 |
